Stephen A. Falk

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

Simron Singh, Daniel Halperin, Sten Myrehaug et al. · The Lancet · 2024 · 250 citations · Full text

Grade 2–3, Endocrine Oncology, Long-acting Octreotide +10

Hospital Noise — Levels and Potential Health Hazards

Stephen A. Falk, Nancy Fúgate Woods · New England Journal of Medicine · 1973 · 173 citations

Noise Levels, Hospital Medicine, Potential Health Hazards +20

Temporary Postthyroidectomy Hypocalcemia

Stephen A. Falk, Eric A. Birken, D. T. Baran · Archives of Otolaryngology - Head and Neck Surgery · 1988 · 104 citations

Anesthesia, Thyroid Disease, Intact Blood Supply +10

Noise‐induced inner ear damage in newborn and adult guinea pigs

Stephen A. Falk, Reginald O. Cook, Joseph K. Haseman et al. · The Laryngoscope · 1974 · 81 citations

Outer Pillar, Pathology, Old Guinea Pigs +17

Thyroid Disease

Stephen A. Falk · The Endocrinologist · 1998 · 64 citations

Part 1, Iodine Deficiency Disorders, Thyroid Disease +11